Research
Hormonal
Muscle satellite cells are a heterogeneous population comprising distinct subpopulations with different self-renewal and differentiation potentials, specifically distinguished by their division rates and expression of markers like Myf5.
Understanding that muscle stem cells (satellite cells) are not all the same is crucial for regenerative medicine. Some are primed for quick repair (differentiation), while others are reserved for long-term maintenance (self-renewal). This balance is key to muscle health and aging.
GoodQualifiesHIGH confidence
accumulating evidence through gene expression profiling and cell surface marker analysis has revealed that satellite cells are a heterogeneous population... satellite cells from different muscle types are not only genetically but also functionally heterogeneous populations
Why this rating
The paper is a review citing multiple primary studies using genetic tracing, transplantation, and molecular analysis in mice.
Source
Muscle satellite cell heterogeneity and self-renewal
Norio Motohashi et al. · Frontiers in Cell and Developmental Biology · 2014
DOI 10.3389/fcell.2014.00001
narrative_reviewCited 259×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Self-renewal of satellite cells is regulated by asymmetric and symmetric division mechanisms, involving specific molecular pathways like p38 MAPK, Notch, and Wnt signaling, which determine whether a cell differentiates or self-renews.Good
- Aging and diseases like Duchenne Muscular Dystrophy (DMD) lead to a decrease in satellite cell number and regenerative capacity due to niche changes and continuous demand, necessitating replenishment strategies.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →